Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease (Q3325996)

From EU Knowledge Graph
Revision as of 14:00, 19 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
Jump to navigation Jump to search
Project Q3325996 in Germany
Language Label Description Also known as
English
Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease
Project Q3325996 in Germany

    Statements

    0 references
    0 references
    70,535.36 Euro
    0 references
    88,169.2 Euro
    0 references
    80.0 percent
    0 references
    2 October 2016
    0 references
    31 October 2019
    0 references
    Technische UniversitätDresden
    0 references
    Q3394796 (Deleted Item)
    0 references
    0 references

    51°2'57.59"N, 13°44'17.30"E
    0 references
    Entwicklung eines PET-Radiopharmakons für die nuklearmedizinische Bildgebung der Parkinson-Krankheit (German)
    0 references
    Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease (English)
    25 October 2021
    0 references
    Développement d’un radiopharmaceutique PET pour l’imagerie nucléaire de la maladie de Parkinson (French)
    6 December 2021
    0 references
    Ontwikkeling van een PET-radiofarmaceutisch geneesmiddel voor de nucleaire beeldvorming van de ziekte van Parkinson (Dutch)
    19 December 2021
    0 references
    Dresden, Stadt
    0 references

    Identifiers

    672 / 101002267521
    0 references